Charles W. Newhall III


Charles W. Newhall, III has served as a member of the Board since 2005. In 1977, Mr. Newhall co-founded New Enterprise Associates, Inc. (NEA), a venture capital firm that focuses on the medical and life sciences and information technology industries. Mr. Newhall has served as a director of over 40 venture-backed companies. He started several healthcare information technology companies, including PatientKeeper, TargetRx, and LifeMetrix. Some of his current Board memberships include Vitae Pharmaceuticals, TargetRx, Sensors for Medicine and Science, and BrainCells Inc. In 1986, he founded the Mid-Atlantic Venture Capital Association (MAVA), which now has over 80 venture capital firms that are members, and is one of the most active regional venture associations in the country. He is now Chairman Emeritus of MAVA. Before NEA, Mr. Newhall was a Vice President of T. Rowe Price.

Mr. Newhall served in Vietnam commanding an independent platoon, including an initial reconnaissance of Hamburger Hill. His decorations include the Silver Star and Bronze Star V (1st OLC). He earned an honors degree in English from the University of Pennsylvania and an MBA from Harvard Business School.

Independent Director
Chairman of the Board